SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
T. Rowe Price Mid-Cap Growth Fund (RPTIX) trades at a trailing P/E of 12.6. Trailing earnings yield is 7.96%. PEG 0.79 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (85/100, Pass) — P/E is below market average (12.6); PEG ≤ 1.0 — Peter Lynch undervalued (0.79); earnings yield beats bond yields (7.96%).
- PEG Ratio 0.79 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 7.96% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
Overall SharesGrow Score: 74/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
85/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — RPTIX
Valuation Multiples
P/E (TTM)12.6
Forward P/EN/A
PEG Ratio0.79
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$7.76
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings Yield7.96%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2014 |
$4.55 |
$3.98B |
$1.22B |
30.5% |
| 2015 |
$4.63 |
$4.2B |
$1.21B |
28.7% |
| 2016 |
$4.75 |
$4.28B |
$1.19B |
27.8% |
| 2017 |
$5.97 |
$4.85B |
$1.46B |
30.2% |
| 2018 |
$7.27 |
$5.37B |
$1.79B |
33.4% |
| 2019 |
$8.70 |
$5.62B |
$2.08B |
37% |
| 2020 |
$9.98 |
$6.21B |
$2.31B |
37.2% |
| 2021 |
$13.12 |
$7.67B |
$3B |
39.1% |
| 2022 |
$6.70 |
$6.49B |
$1.52B |
23.5% |
| 2023 |
$7.76 |
$6.46B |
$1.74B |
27% |
